Robert Lehman
Directeur/Membre du Conseil chez EOM PHARMACEUTICALS HOLDINGS, INC.
Profil
Robert W.
Lehman is currently a Director at EOM Pharmaceuticals Holdings, Inc. He previously served as an Independent Director at ImmunoCellular Therapeutics Ltd.
and as a Senior Partner at Ernst & Young LLP from 1995 to 2021.
He also briefly served as the Chief Financial Officer at Western Asset Mortgage Capital Corp.
from 2022 to 2023.
Lehman received his undergraduate degree from Queens College.
Postes actifs de Robert Lehman
| Sociétés | Poste | Début |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/04/2022 |
Anciens postes connus de Robert Lehman
| Sociétés | Poste | Fin |
|---|---|---|
| WESN ASSEPAR | Directeur Financier/CFO | 06/12/2023 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2021 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | - |
Formation de Robert Lehman
| Queens College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Western Asset Mortgage Capital Corp.
 Western Asset Mortgage Capital Corp. Real Estate Investment TrustsFinance Western Asset Mortgage Capital Corp. operates as a real estate investment trust, which engages in the management of a diversified portfolio of assets. It focuses on investing in financing, and managing real estate related securities, whole loans, and other financial assets. The company was founded on June 3, 2009 and is headquartered in Los Angeles, CA. | Finance |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
